Patents by Inventor Ken Kanada

Ken Kanada has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ORAL DISINTEGRATING TABLET HAVING MASKED BITTER TASTE AND METHOD FOR PRODUCTION THEREOF
    Publication number: 20090311321
    Abstract: The present invention provides an orally disintegrating tablet containing mitiglinide calcium hydrate. The tablet has reduced bitterness and quickly disintegrates in the mouth, while exhibiting rapid dissolution in the digestive tract. The bitterness-masked orally disintegrating tablet comprises: (a) mitiglinide calcium hydrate; (b) microcrystalline cellulose; (c) at least one masking agent selected from the group consisting of aminoalkyl methacrylate copolymer E, polyvinylacetal diethylaminoacetate, an ethyl acrylate-methyl methacrylate copolymer, and ethyl cellulose; (d) a sugar or a sugar alcohol; and (e) at least one selected from corn starch and partially pregelatinized starch.
    Type: Application
    Filed: August 3, 2007
    Publication date: December 17, 2009
    Applicant: KISSEI PHARMACEUTICAL CO., LTD.
    Inventors: Kazuki Mimura, Yasuhiro Takeda, Ken Kanada
  • Immediate release medicinal compositions for oral use
    Patent number: 7166301
    Abstract: The present invention relates to an immediate release oral pharmaceutical composition which comprises as an active ingredient calcium salt of a benzylsuccinic acid derivative represented by the formula: or its hydrate, which is useful as an agent for the treatment of diabetes.
    Type: Grant
    Filed: May 21, 1999
    Date of Patent: January 23, 2007
    Assignee: Kissei Pharmaceutical Co., Ltd.
    Inventors: Kiyohisa Ouchi, Kaoru Kaneko, Ken Kanada
  • Immediate release medicinal compositions for oral use
    Patent number: 7160556
    Abstract: The present invention relates to an immediate release oral pharmaceutical composition which comprises as an active ingredient calcium salt of a benzylsuccinic acid derivative represented by the formula: or its hydrate, which is useful as an agent for the treatment of diabetes.
    Type: Grant
    Filed: April 6, 2004
    Date of Patent: January 9, 2007
    Assignee: Kissei Pharmaceutical Co., Ltd.
    Inventors: Kiyohisa Ouchi, Kaoru Kaneko, Ken Kanada
  • Immediate release medicinal compositions for oral use
    Patent number: 7160555
    Abstract: The present invention relates to an immediate release oral pharmaceutical composition which comprises as an active ingredient calcium salt of a benzylsuccinic acid derivative represented by the formula: or its hydrate, which is useful as an agent for the treatment of diabetes.
    Type: Grant
    Filed: April 6, 2004
    Date of Patent: January 9, 2007
    Assignee: Kissei Pharmaceutical Co., Ltd.
    Inventors: Kiyohisa Ouchi, Kaoru Kaneko, Ken Kanada
  • Immediate release medicinal compositions for oral use
    Publication number: 20040197400
    Abstract: The present invention relates to an immediate release oral pharmaceutical composition which comprises as an active ingredient calcium salt of a benzylsuccinic acid derivative represented by the formula: 1
    Type: Application
    Filed: April 6, 2004
    Publication date: October 7, 2004
    Applicant: KISSEI PHARMACEUTICAL CO., LTD.
    Inventors: Kiyohisa Ouchi, Kaoru Kaneko, Ken Kanada
  • Immediate release medicinal compositions for oral use
    Publication number: 20040192755
    Abstract: The present invention relates to an immediate release oral pharmaceutical composition which comprises as an active ingredient calcium salt of a benzylsuccinic acid derivative represented by the formula: 1
    Type: Application
    Filed: April 6, 2004
    Publication date: September 30, 2004
    Applicant: KISSEI PHARMACEUTICAL CO., LTD.
    Inventors: Kiyohisa Ouchi, Kaoru Kaneko, Ken Kanada